Dr Patrick Lewis

Associate Professor, Schools of Pharmacy, University of Reading

Biography

I have been working on neurodegenerative diseases for over ten years, first at the Mayo Clinic in Florida where I worked on the molecular basis of Alzheimer’s disease. I then carried out graduate studies at the Medical Research Council Prion Unit at the UCL Institute of Neurology where I completed a PhD on the molecular characteristics of the Scrapie agent in 2005. I started working on Parkinson’s disease at the National Institute on Aging in Bethesda in the Laboratory of Neurogenetics under Mark Cookson. It was in Bethesda that I first came across Leucine Rich Repeat Kinase 2, LRRK2, a protein which I have been investigating ever since. In 2007 I returned to the UCL Institute of Neurology and the Department of Molecular Neuroscience.

Related speakers

Keith Anderson

Chief Corporate Officer, ScottishPower

Baroness Tanni Grey-Thompson

Paralympian & Crossbench Peer

Professor Kimberley Scharf

Head of the Department of Economics, University of Birmingham

Kevin Gaskell

Former Director of Porsche & BMW

Professor Sir Tejinder Virdee

Professor of Physics, Imperial College London

Professor Gina Rippon

Professor of Cognitive NeuroImaging, Aston University